Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model
about
Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's diseaseThe neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceNeurodegeneration in Alzheimer's disease: caspases and synaptic element interdependenceNeural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patientsTau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastinHsp90-Tau complex reveals molecular basis for specificity in chaperone actionImmunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyHDAC2 negatively regulates memory formation and synaptic plasticity.Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networksLevetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.Reversing EphB2 depletion rescues cognitive functions in Alzheimer modelProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesNicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotauHyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer diseaseSynapses and Alzheimer's diseaseUntangling tau imagingTemperature and toxic Tau in Alzheimer's disease: new insightsChronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationThe amyloid hypothesis of Alzheimer's disease at 25 yearsEmerging Link between Alzheimer's Disease and Homeostatic Synaptic PlasticityTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseTau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic ParaplegiaSUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?Diverse molecular targets for therapeutic strategies in Alzheimer's diseaseAlzheimer's therapeutics: translation of preclinical science to clinical drug developmentPathogenic protein seeding in Alzheimer disease and other neurodegenerative disordersThe involvement of microRNAs in neurodegenerative diseasesApolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer diseaseBehavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseasesBrain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathiesBreaking the Code of Amyloid-β OligomersThe Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeletonDeveloping therapeutic approaches to tau, selected kinases, and related neuronal protein targetsConnecting the dots between tau dysfunction and neurodegenerationAlternative neural circuitry that might be impaired in the development of Alzheimer diseaseTangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem
P2860
Q21136406-DF7AEE34-7B51-4A40-ABBE-DE4123368C5BQ21195685-EF799D93-15B2-4D84-A396-E2265AB29281Q21202836-A21C035D-0063-4F25-89B6-F32CDC6552B2Q22251259-693D7AA1-26CA-48B8-AFF8-FC5449DD4A74Q24328779-1A02F1C3-D158-4B70-BCA1-F8631E38F31CQ24337233-D4B5B4F6-FD3A-4370-956A-4C8B77669BF8Q24338439-93E89D61-7D8D-430D-AFFF-71B8593C58FCQ24599108-36EC6027-C705-4BEF-BCAB-3F9E30DA00A9Q24603560-931A63F5-FEF0-4E0E-B716-33C5DFB1184CQ24604376-054FD851-7E88-495D-9A84-0B15FF995E76Q24611806-0A2A11F8-7503-498B-B15F-7FA751C8DC27Q24622558-C51818E0-805A-4388-992F-ACA649C38C5BQ24624879-0CAEC3DB-A646-43B1-A523-F14ACF733240Q24632892-CBD29A7D-EEEE-4A85-AD6B-367B30222533Q24650014-FEBD0463-A00C-4CB7-BC4B-74CC54D6BFC2Q24651880-DC406FEB-C5BE-4CAA-AD97-E54DE6B3F4E5Q24657243-3DE92453-05C2-4331-90DD-D9814951A1B0Q26269868-ACBDB11A-15DC-4039-981D-AFC9DC16F1D0Q26739091-D8EF73D4-4919-484C-9E39-829B786C9FA4Q26745778-AC58E484-309A-40F1-863E-88133692B625Q26748974-22CAE33A-7DF5-4BA1-A01E-DD735F6A12D7Q26749528-553D7076-4EBF-4767-9053-9AEF4664648EQ26750576-A235C876-212D-4B14-AA31-E5F1FDA41C0DQ26773154-F60D343F-69A2-44F4-B025-30A127B6FEF0Q26774045-76C85459-E828-425B-BE00-930A6A52BE3BQ26783370-9504BAAB-AF9D-4807-8AB5-6402BD3CD62BQ26827193-BADF65A8-2756-4110-9C4F-EAD41F0866F4Q26829267-EC014EC9-FB11-4C04-A85C-D2C370E7745DQ26850298-E27E949A-B879-4E83-8BC0-13517EB55F74Q26858788-0BC5BD61-B2AB-467B-94B2-2960100A6580Q26858870-2120734A-FF2C-487A-9DE6-EC6E04D45B7EQ26858963-9141A54A-3416-48B3-B84D-257D8CA8FC9AQ26859909-C29D962C-C617-47AA-8318-967B559C2EDFQ26861683-5797966F-7C3B-4B35-96BE-0CC6B19DA77FQ26862630-7DBD7917-FB60-40CD-8096-8CEEC5EF91CAQ26864818-344657F9-C710-4814-B9B1-8B7490E5BBACQ26865654-DFD9A9F1-0B3A-45ED-9CA2-854F675A8123Q26996848-769CAB59-DCB7-4EF5-B870-117444A00D4BQ27001223-382468D1-2FA2-49DB-BEE5-6C6C50280156Q27004724-268FDD47-651C-450B-9809-C3C7D70B555C
P2860
Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Reducing endogenous tau amelio ...... lzheimer's disease mouse model
@ast
Reducing endogenous tau amelio ...... lzheimer's disease mouse model
@en
type
label
Reducing endogenous tau amelio ...... lzheimer's disease mouse model
@ast
Reducing endogenous tau amelio ...... lzheimer's disease mouse model
@en
prefLabel
Reducing endogenous tau amelio ...... lzheimer's disease mouse model
@ast
Reducing endogenous tau amelio ...... lzheimer's disease mouse model
@en
P2093
P3181
P356
P1433
P1476
Reducing endogenous tau amelio ...... lzheimer's disease mouse model
@en
P2093
Fengrong Yan
Gui-Qiu Yu
Hilary Gerstein
Irene H Cheng
Jorge J Palop
Kimberly Scearce-Levie
Lennart Mucke
Tiffany Wu
P304
P3181
P356
10.1126/SCIENCE.1141736
P407
P577
2007-05-01T00:00:00Z